Choi et al. [26] found that the phosphorylation of PPARγ mediated by cyclin-dependent kinase 5 (Cdk5) may be involved in the pathogenesis of insulin resistance, while rosiglitazone can block the phosphorylation of CK5-PPAR. The gene discussed is CDK5; the disease is Insulin resistance.